Holdings of SymBiosis Capital Partners, LLC
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 4 in 2 countries
- Top ten
- 100.0 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Evommune Inc | 1,280,778 | 29.4M $ | |
| 2 | Inventiva SACA | 2,354,000 | 13.1M $ | |
| 3 | Rani Therapeutics Holdings Inc | 3,667,585 | 2.7M $ | |
| 4 | CLENE INC | 431,094 | 2.1M $ |
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 72.4 %
- France 27.6 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 3 | 34.3M $ | 72.40 % |
| 2 | France | 1 | 13.1M $ | 27.60 % |
Cite this page
Titelia. "Holdings of SymBiosis Capital Partners, LLC". https://titelia.com/en/funds/US13F2006045